James D. Reimann

4.0k citations
16 papers · 3.0k indexed · 3 hit papers · h-index 12
Topics
Allergic Rhinitis and Sensitization (5 papers)Asthma and respiratory diseases (5 papers)Food Allergy and Anaphylaxis Research (3 papers)

In The Last Decade

James D. Reimann

16 papers receiving 2.9k citations

Hit Papers

Randomized Phase III Trial of Capecitabine Compared With ...19972026200620162005199719992505007501000

Peers

James D. Reimann
Comparison fields: 5 of 99
  • Physiology 1.1k
  • Oncology 967
  • Immunology and Allergy 864
  • Pulmonary and Respiratory Medicine 813
  • Molecular Biology 607
Replace W. J. Mooi with:
W. J. Mooi Netherlands
G Spencer-Green United States
Aileen L. Pangan United States
Michael Loughnan Australia
Valentin Goede Germany
Taeko Ishii Japan
Louis R. Bégin Canada
Raymond L. Comenzo United States
Frank A. Scappaticci United States
Carl Zuelke Germany
James D. Reimann relative to W. J. Mooi Netherlands W. J. Mooi's profile →
Citations per field
00.5×11.4×
W. J. Mooi · 1×
Citations per year

Countries citing papers authored by James D. Reimann

Since Specialization
Citations

This map shows the geographic impact of James D. Reimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Reimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Reimann more than expected).

Fields of papers citing papers by James D. Reimann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Reimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Reimann. The network helps show where James D. Reimann may publish in the future.

Co-authorship network of co-authors of James D. Reimann

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Reimann. A scholar is included among the top collaborators of James D. Reimann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Reimann. James D. Reimann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 79
2 50
3 37
4 84
5 185
6
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancerbreakdown →
1002
7 24
8 75
9 4
10 204
11 8
12
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibodybreakdown →
520
13
Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma.
2
14
The Effect of an Anti-IgE Monoclonal Antibody on the Early- and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjectsbreakdown →
521
15 244
16 1

About James D. Reimann

James D. Reimann is a scholar working on Immunology and Allergy, Physiology and Gastroenterology, having authored 16 papers that have together received 3.0k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (5 papers), Asthma and respiratory diseases (5 papers) and Food Allergy and Anaphylaxis Research (3 papers). The work is most often cited by research in Immunology and Allergy (864 citations), Physiology (1.1k citations) and Oncology (967 citations). James D. Reimann has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert B. Fick, John Q. Su, Kathy D. Miller, Virginia K. Langmuir, Melody Cobleigh, Hope S. Rugo, Linnea Chap, P. Kelly Marcom, Maura N. Dickler and Beth Overmoyer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026